Skip to content

Twist Bioscience Corporation TWST Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
Revvity logo
RevvityRVTY
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
International Flavors & Fragrances logo
International Flavors & FragrancesIFF

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's common stock, shares authorized (in shares)?
Twist Bioscience Corporation (TWST) reported common stock, shares authorized (in shares) of $200M in Q1 2026.
How has Twist Bioscience Corporation's common stock, shares authorized (in shares) changed year-over-year?
Twist Bioscience Corporation's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $200M to $200M.
What is the long-term trend for Twist Bioscience Corporation's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's common stock, shares authorized (in shares) has grown at a 14.9% compound annual growth rate (CAGR), from $100M to $200M.